跳至主要内容
临床试验/DRKS00000083
DRKS00000083已完成不适用

ong term anticoagulation with low-molecular-weight heparin in a cohort of early neurological rehabilitation patients: does an effective inhibition of activity of factor Xa and factor IIa occur, as well as an increase of tPA and TFPI-levels?

pharmazentrum frankfurtInstitut für Klinische PharmakologieKlinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main0 个研究点目标入组 77 人开始时间: 2009年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • patients of early neurological rehabilitation under therapeutic or prophylactic LMWH treatment
  • patients of early neurological rehabilitation under oral anticoagulant treatment

排除标准

  • necessity of periodical hemodialysis treatment.

研究者

发起方
pharmazentrum frankfurtInstitut für Klinische PharmakologieKlinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main

相似试验

尚未招募
3 期
Investigating the effectiveness of anticoagulants compared to aspirin and clopidogrel on disease severity in patients with ischemic stroke.Cerebral infarction
IRCT20221026056307N1Bojnourd University of Medical Sciences86
进行中(未招募)
1 期
APIDULCIS: Extended anticoagulation treatment with low-dose apixaban in patients with a first venous thromboembolism and a positive d-dimer, who were treated with standard course of anticoagulatioa first episode of proximal deep vein thrombosis (DVT) and/or pulmonary embolism (PE)MedDRA version: 21.0Level: PTClassification code 10037377Term: Pulmonary embolismSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 21.1Level: PTClassification code 10051055Term: Deep vein thrombosisSystem Organ Class: 10047065 - Vascular disorders
EUCTR2017-002340-32-ITFONDAZIONE ARIANNA ANTICOAGULAZIONE1,200
进行中(未招募)
1 期
Comparison of direct thrombin inhibitors versus low molecular weight heparins for the prevention of venous thromboembolism in patients with Staphylococcus aureus bacteraemia.
EUCTR2012-004863-29-BEniversity Hospitals Leuven (Gasthuisberg)
已完成
2 期
the effect of plavix in post coronary artery bypass graft/coronary endarterectomy patientsCoronary artery disease.Atherosclerotic heart disease Coronary (artery): atheroma atherosclerosis disease sclerosis
IRCT2016102730410N2Babol University of Medical Sciences, Deputy of Research & Technology55
进行中(未招募)
1 期
Reduced Anticoagulation Targets in Extracorporeal life supportHeart or lungfailure treated with ECMO
EUCTR2019-004125-24-NLMCG330